


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31198520</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2008-7802</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of preventive medicine</Title>
                <ISOAbbreviation>Int J Prev Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optimal Choice of Pharmacological Therapy - Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>85</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4103/ijpvm.IJPVM_426_18</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">The aim of the study was to highlight the importance of adequate anticoagulant therapy and the correlation of higher risk of stroke.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">This study analyzed data obtained from 103 patients with diagnosis of atrial fibrillation (AF) (39 of them had a stroke). Patients were divided into groups according to the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, and HASBLED scores.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">An analysis showed that anticoagulant drugs were more often prescribed to subjects &lt;75 years of age (<i>P</i> = 0.001). Patients with a higher CHADS<sub>2</sub> score had a higher CHA<sub>2</sub>DS<sub>2</sub>-VASc score and vice versa (rho = 0.513; <i>P</i> = 0.0001). According to the CHA<sub>2</sub>DS<sub>2</sub>-VASc, 91.3% of the patients examined were prescribed an anticoagulant medication as a therapy at discharge from the hospital. The result was statistically significant compared to the practice where an anticoagulant was prescribed to 55.9% of high-risk subjects as estimated by the CHA<sub>2</sub>DS<sub>2</sub>-VASc score (<i>P</i> &lt; 0.05). Our results also show that rivaroxaban is more commonly prescribed as a discharge therapy than warfarin (χ<sup>2</sup> = 12.401; <i>P</i> = 0.0001). Furthermore, a significantly higher number of patients who were being prescribed aspirin (38.5%) had a stroke compared to 12.8% of patients who were being prescribed warfarin (χ<sup>2</sup> = 12.259; <i>P</i> = 0.0001).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Novel oral anticoagulants (NOACs) seem to be a better choice as a pharmacological therapy in the treatment of AF, due to a lack of adequate monitoring of patients' international normalized ratio (INR) values. CHA<sub>2</sub>DS<sub>2</sub>-VASc and HASBLED scores must be used as a part of routine clinical diagnostics when dealing with patients with AF.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hodzic</LastName>
                    <ForeName>Enisa</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Begic</LastName>
                    <ForeName>Edin</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Sarajevo Medical School, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, General Hospital &quot;Prim.dr.Abdulah Nakas&quot;, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zuhric</LastName>
                    <ForeName>Sedina</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zentrum für Anästhesie, Intensivmedizin, Notfallmedizin und Schmerztherapie, SLK Kliniken Heilbronn, Heilbronn, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nalbantic</LastName>
                    <ForeName>Azra Durak</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Begic</LastName>
                    <ForeName>Zijo</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Cardiology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masic</LastName>
                    <ForeName>Izet</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Science Editing, Academy of Medical Sciences in Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Iran</Country>
            <MedlineTA>Int J Prev Med</MedlineTA>
            <NlmUniqueID>101535380</NlmUniqueID>
            <ISSNLinking>2008-7802</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
            <Keyword MajorTopicYN="N">hemorrhage</Keyword>
            <Keyword MajorTopicYN="N">risk</Keyword>
            <Keyword MajorTopicYN="N">stroke</Keyword>
            <Keyword MajorTopicYN="N">therapeutics</Keyword>
        </KeywordList>
        <CoiStatement>There are no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31198520</ArticleId>
            <ArticleId IdType="doi">10.4103/ijpvm.IJPVM_426_18</ArticleId>
            <ArticleId IdType="pii">IJPVM-10-85</ArticleId>
            <ArticleId IdType="pmc">PMC6547788</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

